BPNT1 Polyclonal Antibody, Cy5.5 Conjugated

Product Specifications

Background

Converts adenosine 3'-phosphate 5'-phosphosulfate (PAPS) to adenosine 5'-phosphosulfate (APS) and 3' (2') -phosphoadenosine 5'- phosphate (PAP) to AMP. Has 1000-fold lower activity towards inositol 1,4-bisphosphate (Ins (1,4) P2) and inositol 1,3,4-trisphosphate (Ins (1,3,4) P3), but does not hydrolyze Ins (1) P, Ins (3,4) P2, Ins (1,3,4,5) P4 or InsP6.

Synonyms

PIP; HEL20; 3' (2'),5'-bisphosphate nucleotidase 1; Bisphosphate 3'-nucleotidase 1; PAP-inositol 1,4-phosphatase; BPNT1

Gene ID

10380

Swiss Prot

O95861

Cellular Locus

Cytoplasm, Extracellular matrix

Host

Rabbit

Cross Reactivity

Human, Mouse

Immunogen

2-100/308

Target

BPNT1

Clonality

Polyclonal

Isotype

IgG

Conjugation

Cy5.5

Source

KLH conjugated synthetic peptide derived from human BPNT1

Applications

WB, FCM, IF (IHC-P), IF (IHC-F), IF (ICC)

Purification

Purified by Protein A.

Excitation Emission

675nm/694nm

Concentration

1µg/µl

Dilution

WB (1:300-5000), FCM (1:20-100), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Specificity

This antibody may have minor secondary reactivity to Zinc finger protein 334 (shown to only exist in Human) and pleiotropic regulator 1 due to a 60% sequential sequence similarity in the immunogen range.